🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Celanese (CE) Raises Selling Prices Of Acetic Acid In China

Published 11/23/2016, 09:00 PM
Updated 07/09/2023, 06:31 AM
KOP
-
KRO
-
CE
-
CC
-
USD/CNH
-

Chemical and advanced materials maker Celanese Corporation (NYSE:CE) declared that it is raising the list and off-list selling prices of acetic acid by RMB 150/MT in China. The price hike will be effective immediately or as contracts permit.

Recently, Celanese also raised the list and off-list selling prices of acetic acid by €40/MT in Europe.

Celanese kept its earnings streak alive with a beat in third-quarter 2016. Moreover, its adjusted earnings of $1.67 per share increased 11.3% year over year. In the reported quarter, the company entered into a definitive agreement to fully acquire Forli, Italy-based SO.F.TER. Group, one of the largest independent thermoplastics compounders in the world. This acquisition will nearly double the number of Celanese global engineered materials platforms.

The company retained its expectations of 8–10% growth in adjusted earnings per share for 2016, factoring in the benefits of productivity actions and operational excellence as well as strength of commercial models.

Celanese’s strategic measures including productivity and efficiency improvement actions should lend support to its earnings in 2016. Further, the company is expected to gain from capacity expansion and growth initiatives in the emerging regions. Moreover, Celanese continues to generate strong cash flows and remains focused on returning value to its shareholders.

Celanese currently carries a Zacks Rank #2 (Buy).

Stocks to Consider

Some other well-placed companies in the chemical space include Koppers Holdings Inc. (NYSE:KOP) , The Chemours Company (NYSE:CC) and Kronos Worldwide, Inc. (NYSE:KRO) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Koppers Holdings has an expected long-term growth of 10%.
Chemours has an expected long-term growth of around 15.5%.
Kronos Worldwide has an expected long-term growth of around 5%.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



CELANESE CP-A (CE): Free Stock Analysis Report

KRONOS WORLDWD (KRO): Free Stock Analysis Report

KOPPERS HOLDNGS (KOP): Free Stock Analysis Report

CHEMOURS COMPNY (CC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.